Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Gross Profit (2020 - 2025)

Biofrontera has reported Gross Profit over the past 6 years, most recently at $14.1 million for Q4 2025.

  • Quarterly results put Gross Profit at $14.1 million for Q4 2025, up 93.35% from a year ago — trailing twelve months through Dec 2025 was $30.7 million (up 64.26% YoY), and the annual figure for FY2025 was $30.7 million, up 64.27%.
  • Gross Profit for Q4 2025 was $14.1 million at Biofrontera, up from $4.9 million in the prior quarter.
  • Over the last five years, Gross Profit for BFRIW hit a ceiling of $14.1 million in Q4 2025 and a floor of -$7.3 million in Q4 2022.
  • Median Gross Profit over the past 5 years was $4.5 million (2021), compared with a mean of $5.4 million.
  • Biggest five-year swings in Gross Profit: plummeted 181.57% in 2022 and later soared 263.03% in 2023.
  • Biofrontera's Gross Profit stood at $9.0 million in 2021, then plummeted by 181.57% to -$7.3 million in 2022, then soared by 263.03% to $12.0 million in 2023, then crashed by 39.02% to $7.3 million in 2024, then skyrocketed by 93.35% to $14.1 million in 2025.
  • The last three reported values for Gross Profit were $14.1 million (Q4 2025), $4.9 million (Q3 2025), and $6.4 million (Q2 2025) per Business Quant data.